[1]
V. A. Rajadnya and A. G. Dhavalshankh, “Cost comparisons of seven leading brands of the Hypolipidemic drug, Rosuvastatin available in an India city”, Int J Basic Clin Pharmacol, vol. 8, no. 7, pp. 1514–1517, Jun. 2019.